• Biohaven Showcases Positive Data on Rimegepant, Oral CGRP Receptor Antagonist, with 16 …

    NEW HAVEN, Conn., July 11, 2019 /PRNewswire/ — Biohaven Pharma Holding Company Ltd. (NYSE: BHVN), today announced it will present 16 …

    Read More
  • 0 0